Introduction
============

Clinically isolated syndrome (CIS) is the first manifestation of most MS patients ([@B32]; [@B25]). The conversion rate of CIS to MS is highly variable from 8--80% depending on the clinical presentation, MRI features, serum biomarkers and follow up period ([@B26]). Many previous studies have demonstrated brain atrophy ([@B6]; [@B1]), diffusion abnormalities ([@B8]; [@B40]; [@B9]; [@B20]), or functional alterations ([@B39]; [@B13]; [@B37]; [@B45]) in CIS and MS. However, the brain is an integrative complex network that cannot be fully understood without proper knowledge of the brain's topology ([@B5]; [@B43]).

Both structural and functional network studies have demonstrated altered network metrics such as decreased global and local efficiency in MS ([@B14]; [@B42]; [@B24]), and its relationship with clinical disability ([@B42]; [@B41]). However, it is still unknown how network changes on a functional level relate to a structural level for MS, highlighting the need for combined functional and structural network studies. Furthermore, previous network studies have mainly focused on global and regional topological properties ([@B14]; [@B42]; [@B41]; [@B38]; [@B44]). The brain networks have also been shown to be highly modularized ([@B4]; [@B15]). Detection and characterization of modular structure in the brain system can help us to identify groups of anatomically and/or functionally associated components. Alterations in the modular organization of the brain in CIS and different MS subtypes have been also shown for structural ([@B18]; [@B29]) and functional networks ([@B11]), even with longitudinal approaches ([@B10]). These findings suggested module-specific topological properties may be more sensitive and specific than global and regional properties to reflect brain alterations and predict the clinical disability in CIS and MS.

Thus, the aim of the present study using diffusion and rs-fMRI techniques combined with graph theoretical analysis was to investigate: (i) whether the module efficiency of structural and functional networks is affected in CIS, (ii) the differences of structural and functional modules between CIS and MS, and (iii) the relationship between structural and functional alterations and their association with clinical variables.

Materials and Methods {#s1}
=====================

Participants
------------

We recruited 41 CIS patients (optic neuritis, *n* = 18; spinal cord syndrome, *n* = 16; brainstem syndrome, *n* = 5; cerebellar syndrome, *n* = 2), 32 relapsing-remitting MS patients and 35 healthy controls (HC). All CIS patients were prospectively examined within 6 months from onset with a single clinical episode suggestive of MS ([@B26]) before steroid treatment. Fifteen CIS patients fulfilled the 2010 modified McDonald Criteria in space dissemination, while none fulfilled the time dissemination. Other patients (*n* = 26) presented with normal brain MRI. All RRMS patients were diagnosed according to the 2010 modified McDonald Criteria ([@B34]) and required to be relapse-free and without treatment with disease-modifying medications or steroids in the 4 weeks prior to MRI scanning. All of the participants were right-handed, as measured by the Edinburgh Inventory ([@B33]). The study was approved by the local Institutional Medical Ethics Committee and all participants gave written informed consent.

Clinical Evaluation
-------------------

The main demographic and clinical characteristics (**Table [1](#T1){ref-type="table"}**), including the Expanded Disability Status Scale (EDSS) score ([@B19]), the disease duration, the MMSE and the Paced Auditory Serial Addition Test (PASAT2 and PASAT3 versions) were assessed by an experienced neurologist (HD).

###### 

The demographic information and clinical characteristics of all participants.

                                   Controls (*n* = 35)   CIS (*n* = 41)   MS (*n* = 32)   F/T/χ^2^/Z value   *P* value
  -------------------------------- --------------------- ---------------- --------------- ------------------ -----------
  Mean Age (years)                 35.0 ± 11.5           35.7 ± 10.7      34.8 ± 8.3      0.08\#             0.92\#
  Gender (F/M)                     23/12                 26/15            24/8            1.17^‡^            0.56^‡^
  Mean MMSE                        29.1 ± 1.3            27.6 ± 1.4       25.9 ± 1.8      36.44\#            \<0.001\#
  Mean PASAT2                      46.7 ± 9.2            39.4 ± 7.7       35.4 ± 9.8      14.14\#            \<0.001\#
  Mean PASAT3                      53.9 ± 6.2            47.5 ± 7.6       41.0 ± 8.7      24.38\#            \<0.001\#
  Mean disease duration (months)   \-                    2.6 ± 2.5        41.8 ± 28.7     8.73\*             \<0.001\*
  Mean TWMLL (ml)                  \-                    4.5 ± 10.6       10.3 ± 10.4     2.33\*             0.023\*
  Median EDSS (range)              \-                    2.0 (0--6)       3.5 (0--6.5)    3.35§              \< 0.001§

CIS, clinically isolated syndrome; MS, multiple sclerosis; MMSE, Mini-Mental State Examination; PASAT = Paced Auditory Serial Addition Test; EDSS, Expanded Disability Status Scale; TWMLL, Total White Matter Lesion Load. Data are mean ± standard deviation, except for EDSS presented in median (range).
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MRI Data Acquisition
--------------------

The MRI data was acquired using a SIEMENS TRIO 3T scanner in the Department of Radiology, Xuanwu Hospital. All participants underwent high-quality MRI scanning, which included a 3D T1-weighted MRI scan \[176 sagittal slices, slice thickness = 1 mm, repetition time (TR) = 1600 ms, echo time (TE) = 2.13 ms, field of view (FOV) = 224 mm × 256 mm, acquisition matrix = 224 × 256\], a T2-weighted MRI scan (35 axial slices, slice thickness = 4 mm, TR = 5000 ms, TE = 87 ms, FOV = 256 mm× 256 mm, acquisition matrix = 256 × 256), a DTI scan (60 axial slices, slice thickness = 2 mm, 30 diffusion directions with *b* = 1000 s/mm^2^, and an additional b0 image, TR = 11000 ms, TE = 98 ms, FOV = 256 mm × 256 mm, acquisition matrix = 128 × 128, average = 2) and a rs-fMRI scan (40 axial slices, slice thickness = 3 mm, TR = 2000 ms, TE = 30 ms, FOV = 220 mm × 220 mm, acquisition matrix = 64 × 64, 180 image volumes).

MRI Data Preprocessing
----------------------

### DTI Data Preprocessing

The preprocessing procedure for DTI data included eddy current and motion artifact correction, estimation of the diffusion tensor and calculation of the fractional anisotropy (FA). First, the eddy current distortions and the motion artifacts in the DTI data were corrected by applying an affine alignment of the diffusion-weighted images to the b0 images. Accordingly, the *b*-matrix was reoriented based on the transformation matrix. After this process, the diffusion tensors were estimated by solving the Stejskal and Tanner equation ([@B2]), and the reconstructed tensor matrix was diagonalized to obtain 3 eigenvalues (λ1, λ2, λ3) and their corresponding eigenvectors. The FA value of each voxel was also calculated. The preprocessing of DTI data was performed with the FDT toolbox in FSL^[1](#fn01){ref-type="fn"}^.

### rs-fMRI Data Preprocessing

The preprocessing of rs-fMRI data included motion correction, brain extraction, spatial smoothing, band-pass filtered (0.01 -- 0.1 Hz) the data and regressed out nuisance covariates, including six rigid body motion parameters, volumes corresponding to motion spikes, and average WM, cerebrospinal fluid (CSF), and global time series. The first 10 functional volumes were discarded to allow for stabilization of the initial signal and adaptation of the participants to the circumstances. The preprocessing of rs-fMRI data was performed with SPM8^[2](#fn02){ref-type="fn"}^ and DPARSF software^[3](#fn03){ref-type="fn"}^ ([@B49]).

### Measurement of WM Lesion Load

Hyperintense white matter (WM) lesions of each patient were manually delineated on the T2-weighted images by an experienced radiologist (YL) who was blind to the clinical details using MRIcro software^[4](#fn04){ref-type="fn"}^. Then the total WM lesion load (TWMLL) for each patient was calculated.

Network Construction
--------------------

Nodes and edges are the two fundamental elements of a network. In this study, we constructed individual structural and functional connectomes using the following procedures.

### Network Node Definition

The Automated Anatomical Labeling (AAL) template ([@B46]) was used to define the network nodes. Briefly, individual T1-weighted images were coregistered to the b0 images in the DTI space. The transformed T1 images were segmented into gray matter (GM), WM and CSF, and then non-linearly transformed to the ICBM152 T1 template in the MNI space. The inverse transformations were used to warp the AAL atlas from the MNI space to the DTI native space. Using this procedure, we obtained 90 cortical and subcortical ROIs (45 for each hemisphere, see **Table [2](#T2){ref-type="table"}**), each representing a node of the network. To ensure the consistency of brain parcellation maps, all rs-fMRI images were also coregistered with b0 image. The results of coregistration were visually checked for each participant by an experienced neuroscientist (NS) with 10 years experience in image analysis. All the procedure was performed using SPM8 software.

###### 

Cortical and subcortical regions of interest defined in the study.

  Index     Regions                                     Abbreviations   Index     Regions                                                 Abbreviations
  --------- ------------------------------------------- --------------- --------- ------------------------------------------------------- ---------------
  (1,2)     Precental gyrus                             PreCG           (47,48)   Lingual gyrus                                           LING
  (3,4)     Superior frontal gyrus, dorsolateral        SFGdor          (49,50)   Superior occipital gyrus                                SOG
  (5,6)     Superior frontal gyrus, orbital part        ORBsup          (51,52)   Middle occipital gyrus                                  MOG
  (7,8)     Middle frontal gyrus                        MFG             (53,54)   Inferior occipital gyrus                                IOG
  (9,10)    Middle frontal gyrus, orbital part          ORBmid          (55,56)   Fusiform gyrus                                          FFG
  (11,12)   Inferior frontal gyrus, opercular part      IFGoperc        (57,58)   Postcentral gyrus                                       PoCG
  (13,14)   Inferior frontal gyrus, triangular part     IFGtriang       (59,60)   Superior parietal gyrus                                 SPG
  (15,16)   Inferior frontal gyrus, orbital part        ORBinf          (61,62)   Inferior parietal, but supramarginal and angular gyri   IPL
  (17,18)   Rolandic operculum                          ROL             (63,64)   Supramarginal gyrus                                     SMG
  (19,20)   Supplementary motor area                    SMA             (65,66)   Angular gyrus                                           ANG
  (21,22)   Olfactory cortex                            OLF             (67,68)   Precuneus                                               PCUN
  (23,24)   Superior frontal gyrus, medial              SFGmed          (69,70)   Paracentral lobule                                      PCL
  (25,26)   Superior frontal gyrus, medial orbital      ORBsupmed       (71,72)   Caudate nucleus                                         CAU
  (27,28)   Gyrus rectus                                REC             (73,74)   Lenticular nucleus, putamen                             PUT
  (29,30)   Insula                                      INS             (75,76)   Lenticular nucleus, pallidum                            PAL
  (31,32)   Anterior cingulate and paracingulate gyri   ACG             (77,78)   Thalamus                                                THA
  (33,34)   Median cingulate and paracingulate gyri     DCG             (79,80)   Heschl gyrus                                            HES
  (35,36)   Posterior cingulate gyrus                   PCG             (81,82)   Superior temporal gyrus                                 STG
  (37,38)   Hippocampus                                 HIP             (83,84)   Temporal pole: superior temporal gyrus                  TPOsup
  (39,40)   Parahippocampal gyrus                       PHG             (85,86)   Middle temporal gyrus                                   MTG
  (41,42)   Amygdala                                    AMYG            (87,88)   Temporal pole: middle temporal gyrus                    TPOmid
  (43,44)   Calcarine fissure and surrounding cortex    CAL             (89,90)   Inferior temporal gyrus                                 ITG
  (45,46)   Cuneus                                      CUN                                                                               

The regions are listed in terms of a prior template of an AAL-atlas (

Tzourio-Mazoyer et al., 2002

).

### Structural Connectome

Diffusion MRI tractography was performed to reconstruct the whole-brain fiber streamlines with Diffusion Toolkit^[5](#fn05){ref-type="fn"}^. All the tracts in the dataset were computed by seeding each voxel with an FA greater than 0.2. The tractography was terminated if it turned an angle greater than 45 degrees or reached a voxel with an FA less than 0.2 ([@B27]). Two brain regions were considered structurally connected if there were at least three fiber streamlines with two end-points located in these two regions ([@B42]). Then, the number of the interconnecting streamlines between two regions was defined as the weights of the network edges. Therefore, for each participant, a weighted 90 × 90 structural connectivity (SC) network was constructed (**Figure [1](#F1){ref-type="fig"}**).

![The flowchart of structural and functional connectome construction. **(A)** Individual T1 images and AAL template were used for automatic parcellation of the cortex into 90 brain regions, forming the nodes of the individual brain networks. **(B)** Streamline tractography was applied to the DTI data to reconstruct the white matter pathways. From the set of reconstructed streamlines, the streamlines that interconnected regions *i* and *j* from the set of 90 regions were taken as an edge between nodes *i* and *j* in the structural brain network. The streamline count was taken to represent the weight of the connection and was aggregated into a structural connectivity (SC) matrix **(C)**. **(D)** Functional connectivity (FC) between nodes *i* and *j* was computed as the level of correlation between their rs-fMRI and blood oxygenation level dependent (BOLD) time series, resulting in a matrix, FC **(E)**. Module parcellation was performed based on the FC backbone to parcellate the brain network into different modules **(F)**. For details, see the Section "Materials and Methods."](fnhum-12-00138-g001){#F1}

### Functional Connectome

Based on the brain parcellation map and coregistered rs-fMRI images, the Pearson correlation coefficient of mean time-series between any pair of ROIs (within GM voxels) and their corresponding significance levels (i.e., *p*-values) were calculated. For each participant, a weighted 90 × 90 functional connectivity (FC) network was constructed (**Figure [1](#F1){ref-type="fig"}**). To remove the spurious correlations in the FC networks, a thresholding procedure was used to convert the correlation matrices derived above to sparse, weighted networks. Specifically, we employed network sparsity (S) (defined as the number of existing edges divided by the maximum possible number of edges in a network) as the thresholding measurement in this study. For example, at a sparsity 10%, the strongest 10% correlations were filtered and retained in individual networks while the others were set to 0. Given the lack of a conclusive way to select a single threshold, individual correlation matrices were thresholded over a consecutive sparsity range of 0.05 \< S \< 0.40 (interval = 0.025). All the above procedures were performed with the GRETNA^[6](#fn06){ref-type="fn"}^ ([@B47]) and DPARSF software ([@B49]).

Module Parcellation of Functional Brain Connectome
--------------------------------------------------

Through modular parcellation, the FC network can be divided into different functional modules composed of regions with similar functions ([@B15]), while not for the SC network. To investigate the SC and FC alterations in specific functional systems, the module parcellation was only applied to functional brain connectome. First, significantly positive FCs were detected by performing a non-parametric one-tailed sign test and were assigned the average edge weight (FC strength) across all participants to combine as a backbone network. Second, based on the FC backbone, module detection was performed with an optimized simulated annealing approach ([@B30]) to parcellate the brain network into different modules. Briefly, the aim of this module identification process is to find a specific partition (p) which yields the largest network modularity, Q(p), which quantifies the difference between the number of intra-module links of actual network and that of random network in which connections are linked at random. The modularity Q(p) for a given partition p of the brain network is defined as ([@B31]):
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where N~m~ is the number of modules, L is the number of connections in the network, l~s~ is the number of connections between nodes in module s, and d~s~ is the sum of the degrees of the nodes in module *s*.

Communication Efficiency Within and Between Modules
---------------------------------------------------

Topological efficiency within and between specific functional modules was proposed by us for the first time to quantify the local information processing within modules and the information exchange between modules, respectively. If each module was considered as a subgraph, the intra-module efficiency measures the efficiency of information processing within this subgraph, which reflects the extent of functional segregation within different modules. Inter-module efficiency reflects the efficiency of information exchange between different modules, which reflects the extent of functional integration across modules.

### Intra-Module Efficiency

The intra-module efficiency measures the global efficiency of the parallel information transfer within the same module, which can be computed as follows:
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where N is the number of nodes in module M, i and j are the nodes in module M, and L~ij~ is the shortest path length between node i and node j within the same module M. The shortest path length, L~ij~, is defined as the sum of the edge lengths (the reciprocal of the edge weight, 1/w~ij~) along the path between node *i* and node *j* with the shortest length.

### Inter-Module Efficiency

The inter-module efficiency measures the global efficiency of the parallel information transfer between two different modules, which can be computed as follows:
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Where N~pq~ is the total number of nodes in modules M~p~ and M~q~, *i* and *j* are the nodes in modules M~p~ and M~q~ respectively, and L~ij~ is the shortest path length between node *i* and node *j* in two different modules. All code for module efficiency is available upon request.

As the modular structure based on the FC backbone was identified, we applied this modular parcellation into both SC and FC networks, and calculated the intra- and inter-module efficiency for both SC and FC networks individually. For the FC network, the module efficiency was calculated at each sparsity level, resulting in curves or functions of the sparsity threshold. Then, the area under curve (AUC) values of the module efficiency were calculated for each participant.

Statistical Analysis
--------------------

Demographic factors, including age and gender, among the three groups were compared using ANOVA or the χ2 test. For the group comparisons of the module efficiency, we performed one-way ANOVA, and *post hoc* pairwise comparisons were performed using two-sample *t*-test if ANOVA yielded significant results (*p* \< 0.05, corrected). To investigate the relationship between structural and functional alterations in module efficiency, partial correlation analysis was performed across all patients, while including the group effect as a covariate. Additionally, correlation coefficients between the altered module efficiency and clinical variables (EDSS, disease duration, PASAT and MMSE) were calculated in each patient group. We chose *p* \< 0.001 as the threshold of significance to correct for multiple comparisons. All of the above statistical analyses were implemented using the Matlab program (The MathWorks, Inc.).

Results
=======

Demographic and Clinical Characteristics
----------------------------------------

There were no significant differences in age (*p* = 0.92) or gender (*p* = 0.56) among the three groups. As for neuropsychological tests, both patient groups showed lower MMSE, PASAT2 and PASAT3 scores than the HC, and the MS patients exhibited lower MMSE and PASAT scores than the CIS group. Eight CIS patients (8/41; 19.5%) and 19 MS patients (19/32; 59.4%) had abnormal PASAT3 performance, and 3 CIS patients (3/41; 7.3%) and 8 MS patients (8/32; 25.0%) had abnormal PASAT2 performance, by defining ≥ 2SD below the average score of HC as abnormal. In addition, MS patients had larger TWMLLs, longer disease durations and higher EDSS scores than CIS patients (**Table [1](#T1){ref-type="table"}**).

Modular Organization of Functional Brain Connectome
---------------------------------------------------

A significant modular architecture of the FC backbone network across all participants was identified (Q~max~ = 0.56), separating the brain into five different modules (**Figure [2](#F2){ref-type="fig"}**). Module I consists of 22 regions mostly from sensory-motor, parietal and temporal cortices, such as bilateral precentral and postcentral gyrus, supplementary motor area, paracentral lobule, supramarginal gyrus, insula, rolandic, superior temporal gyrus and heschl's gyrus that are mainly associated with the somatosensory, motor and auditory functions (sensory-motor network, SMN). Module II is composed of 14 regions from occipital lobe, including bilateral superior, middle and inferior occipital gyrus, calcarine fissure, cuneus, lingual gyrus and fusiform gyrus that are primarily specialized for visual processing (visual network, VN). Module III includes 36 regions from medial frontal and parietal regions and lateral temporal cortices, such as bilateral superior frontal gyrus, orbital part of middle and inferior frontal gyus, anterior and posterior cingulate cortices, precuneus, angular gyrus, hippocampus and parahippocampal gyrus, middle and inferior temporal gyrus, which are key components of the default-mode network (DMN) ([@B35]). Module IV is composed of 8 inferior frontal and parietal regions, including bilateral inferior frontal gyus (both opercular and triangular parts), superior parietal gyrus and inferior parietal lobule that are known to be predominantly involved in attention processing (fronto-parietal network, FPN). The final Module V includes 10 paralimbic and subcortical regions, such as bilateral middle cingulate gyrus, thalamus, caudate, putamen and palladium that are mainly composed of the subcortical system (subcortical network, SUB). Notably, the bilateral homotopic regions were parcellated into the same module. The modular structure of functional brain network is highly consistent with the findings of previous studies ([@B15]).

![Modular organization of the functional brain connectome. Five functional modules were identified based on the functional backbone network, which are represented in five different colors overlaid on the cortical surface **(A)** and are shown on the backbones of SC and FC networks with different colors in nodes **(B)** (red: SMN; green: VN; blue: DMN; cyan: FPN; magenta: SUB).](fnhum-12-00138-g002){#F2}

Group Differences in Module Efficiency of Structural and Functional Connectomes
-------------------------------------------------------------------------------

For the module efficiency of the SC network, we found significant group differences within SMN, within VN, between SMN and VN, between SMN and FPN, between FPN and SUB, and between DMN and all other modules (all *p* \< 0.05, Bonferroni correction) (**Figure [3A](#F3){ref-type="fig"}**). A trend of group difference between SMN and SUB (*p* = 0.004) was also identified. *Post hoc* analyses revealed that MS patients had decreased values in all of the above intra- and inter-module efficiency relative to both HC and CIS patients (all *p* \< 0.05). Furthermore, the CIS patients showed decreased inter-module efficiencies between SMN and VN (*p* = 0.0088), between SMN and DMN (*p* = 0.025), between SMN and FPN (*p* = 0.014) and between VN and DMN (*p* = 0.017) when compared with controls.

![Decreased module efficiency of the SC and FC networks in CIS and MS patients. The bar and error bar represent the mean values and standard deviations of the module efficiency in each group. **(A)** Significantly reduced module efficiency of the SC networks was observed in both CIS and MS patients relative to the controls (all *p* \< 0.05, corrected). **(B)** Significantly decreased inter-module efficiency was found in the FC networks in MS patients relative to controls and CIS patients. ^∗^*p* \< 0.05; ^∗∗^*p* \< 0.01; ^∗∗∗^*p* \< 0.005. **(C)** Significant correlations were identified between the decreased module efficiency of the SC network and FC network across all patients (*p* \< 0.001). ModEff, module efficiency; FCN, functional connectivity network; SCN, structural connectivity network.](fnhum-12-00138-g003){#F3}

For the module efficiency of the FC network, significant group differences were found between SMN and FPN and between VN and FPN (all *p* \< 0.005, uncorrected) (**Figure [3B](#F3){ref-type="fig"}**). MS patients showed decreased values relative to both HC and CIS patients in all of those inter-module efficiencies. No differences were found between CIS patients and the HC (all *p* \> 0.05).

For the relationship between SC and FC alterations across all patients, we found that the decreased inter-module efficiency between SMN and FPN of the FC network was significantly correlated with the decreased inter-module efficiency between FPN and SUB (*r* = 0.33; *p* = 0.0005) and that between SMN and SUB (*r* = 0.33; *p* = 0.0006) of the SC network (**Figure [3C](#F3){ref-type="fig"}**). For each patient group (CIS or MS), similar correlation results between structural and functional alterations were found.

Relationship Between Decreased Module Efficiency and Clinical Variables
-----------------------------------------------------------------------

For the MS patients, module efficiency in the SC network was significantly correlated with the EDSS, PASAT2 and PASAT3 scores (all *p* \< 0.001) (**Figure [4](#F4){ref-type="fig"}**). Specifically, increased EDSS scores were correlated with decreased module efficiency of the SC network within SMN (*r* = -0.58; *p* = 0.0006), and between SMN and VN (*r* = -0.58; *p* = 0.0007). The decreased PASAT2 scores were correlated with the decreased module efficiency of the SC network between VN and SUB (*r* = 0.58; *p* = 0.0004). The decreased PASAT3 scores were correlated with the deceased module efficiency of the SC network within VN (*r* = 0.62; *p* = 0.0002), between VN and SUB (*r* = 0.62; *p* = 0.0001), and between DMN and FPN (*r* = 0.56; *p* = 0.0008). No significant correlations were identified between altered module efficiency and disease duration. Furthermore, no correlations with clinical variables were found in the CIS group (all *p* \> 0.05).

![Correlation between decreased module efficiency and clinical variables. Plots showing the linear correlation between altered module efficiency of the SC networks with EDSS **(A)**, PASAT2 **(B)**, and PASAT3 **(C)** scores in MS patients (all *p* \< 0.001).](fnhum-12-00138-g004){#F4}

Effect of TWMLL on Modular Analysis
-----------------------------------

To exclude the TWMLL effect on the module analysis, we have repeated the statistical analyses by adding the TWMLL as a covariate. Most of the results remained largely unchanged, but less significance of group differences in the intra- and inter-module efficiency were found, which may be due to part contribution of TWMLL to the group differences in module efficiency. The detailed results of group differences and clinical correlations were as follows:

### Between-Group Differences

For the module efficiency of the SC network, we found significant group differences within SMN, within VN, between SMN and VN, between VN and SUB, between FPN and SUB, and between DMN and all other modules (all *p* \< 0.01, uncorrected). A trend of group difference between SMN and FPN (*p* = 0.02), between SMN and SUB (*p* = 0.03) and within DMN (*p* = 0.03) was also identified. *Post hoc* analyses revealed that MS patients had decreased values in all of the above intra- and inter-module efficiency relative to both HC and CIS patients (all *p* \< 0.05). Furthermore, the CIS patients showed decreased inter-module efficiencies between SMN and VN (*p* = 0.01), between SMN and DMN (*p* = 0.04), between SMN and FPN (*p* = 0.03) and between VN and DMN (*p* = 0.03) when compared with controls.

For the module efficiency of the FC network, significant group differences were found between SMN and FPN (*p* = 0.008) and between VN and FPN (*p* = 0.01). MS patients showed decreased values relative to both HC and CIS patients in all of those inter-module efficiencies. No differences were found between CIS patients and the HC (all *p* \> 0.05).

### Clinical Correlations

For the MS patients, module efficiency in the SC network was significantly correlated with the EDSS, PASAT2 and PASAT3 scores (all *p* \< 0.05). Specifically, increased EDSS scores were correlated with decreased module efficiency of the SC network within SMN (*r* = -0.40; *p* = 0.030), and between SMN and VN (*r* = -0.42; *p* = 0.023). The decreased PASAT2 scores were correlated with the decreased module efficiency of the SC network between VN and SUB (*r* = 0.61; *p* = 0.0004). The decreased PASAT3 scores were correlated with the deceased module efficiency of the SC network within VN (*r* = 0.62; *p* = 0.0003), between VN and SUB (*r* = 0.61; *p* = 0.0004), and between DMN and FPN (*r* = 0.52; *p* = 0.003). No correlations were found in the CIS group (all *p* \> 0.05).

Discussion
==========

In the present study, we investigated the alterations in the module efficiencies of structural and functional networks in CIS and MS patients by combining DTI and rs-fMRI with graph theoretical approaches. Our results demonstrated the following: (i) at the earliest stage of MS (CIS), structural network changes were mainly located in inter-modules without significant functional network alterations; (ii) more widespread and severe alterations in structural and functional networks were observed in MS; (iii) the correlation between decreased SC and FC connections were mediated by a subcortical network; and (iv) the reduced module efficiency of structural networks was associated with cognitive impairment and physical disability in MS.

Recent brain network studies have consistently revealed that the modular structure is a non-trivial property of the brain connectome, which supports for the functional specialization and segregation of the human brain ([@B4]). By detecting the modules of the functional connectome, we parcellated the brain into different functional systems, which are comparable with previously reported modular decompositions of rs-fMRI networks ([@B15]; [@B48]). Importantly, the concept of module efficiency was proposed here, which is used to quantify the communication efficiency within and between different functional systems based on the structural or functional connectivity network. The loss or reorganization of the SC or FC in disease populations can be detected by the alterations of the module efficiency, and can be specified to different functional systems.

In the earliest stage of MS (CIS), the predominant decreased module efficiency of SC networks is located between modules of the SMN, VN, DMN and FPN, which indicates that a long-distance connection was mainly involved at the earliest stage of disease. This is consistent with the previous findings with long WM fibers, such as the corpus callosum damage in CIS ([@B36]), inducing structural inter-module disconnection. Various pathological factors such as axonal damage, demyelination and gliosis may contribute to the inter-module disconnection ([@B7]). In MS, much widespread and severe SC reduction was identified, especially in intra-module connections. The intra-module disconnection is mainly caused by short WM fiber damage or cortical demyelination. This result revealed the dynamic changes of the structural network from inter-modules to widespread changes, including both inter- and intra-modules with disease progression.

No significant alterations in the FC network were identified in CIS, implying that the functions were relatively preserved in CIS although structural disconnections were observed. For MS, inter-module disruptions between the SMN, VN and FPN of the FC network were identified, and SC changes were also observed in these inter-module connections. This finding supports the notion that SC damage may precede functional changes and need to achieve a threshold to cause functional impairment. According to previous studies with controversial findings in CIS and MS patients, decreased or increased functional connectivity or regional spontaneous activity was identified ([@B39]; [@B3]; [@B13]; [@B23], [@B22]; [@B37]). However, most of these studies used independent component analysis (ICA) or amplitude of low frequency fluctuation (ALFF) methods; our finding using a graph analysis approach suggested decreased FC in both CIS and MS patients from system level, which reflect impaired information processing within and between modules. The different analysis methods (different aspects of brain functional alterations) or the heterogeneity of patients (cognitively preserved or impaired, different disease phases, etc.) may help explain the discrepancies among the different studies.

The widespread structural network changes, in contrast to the relatively mild/limited functional network changes, indicate the partial disassociation between the structural damage and functional impairment/reorganization observed in MS patients. As suggested by previous studies, the relationship between structural and functional connectivity in the healthy human brain is complicated and is not a simply one-to-one correspondence ([@B17]; [@B16]; [@B12]). In disease states, the relationship between brain structure and function may be more complicated. Quantitative analysis revealed that decreased FCs of the SMN-FPN are correlated with reduced SCs of the SMN-SUB and the FPN-SUB in patients, highlighting the subcortical network as a key mediator for structural and functional association, and suggesting the possible structural substrate of functional deficits. Subcortical structures, such as the thalamus, play an important role in signal relay and regulation to the cerebral cortex. Additionally, subcortical damage has been well demonstrated in MS patients ([@B21]; [@B44]). The relationship between indirect structural connections between the SMN and FPN through the subcortical structures and the functional synchronization between regions of the SMN and FPN should be further studied.

Importantly, both intra- and inter-module efficiencies of SC networks were associated with cognitive scores in MS, suggesting that the SC module efficiency may provide potential biomarkers for assessing and monitoring cognitive impairment in patients. SC module efficiency especially in the SMN module, also showed a moderate correlation with EDSS, indicating that SC networks should also be assessed to evaluate physical disability in MS. A clinical correlation was observed in module efficiency of SC but not FC network, implying that SC is a more robust biomarker for clinical deficits. No significant correlations between module efficiency and clinical variables were observed in CIS patients, implying the module changes in CIS may represent a transitional phase, which need to be validated by a large sample study.

Several limitations should be addressed. First, the samples were obtained from a cross-sectional design, whereas future studies with longitudinal MRI data will be required to validate the findings. Second, deterministic tractography was used for the reconstruction of WM tracts, which may result in the loss of existing fibers due to WM lesions in the patients or the "fiber crossing" problem ([@B28]). Future studies should employ more advanced tractography techniques to define the network edges. Third, we only used the anatomical AAL atlas to define network nodes, the test-retest validity of our findings should be examined with some other parcellation schemes with more precise anatomical or functional boundary of the brain regions and more even regional size. Finally, the cognitive assessment only includes PASAT in the current study; comprehensive neuropsychological tests for CIS and MS patients should be examined to evaluate the relationship between alterations of module efficiency and cognitive impairment in different cognitive domains in future studies.

Conclusion
==========

Our results demonstrated early structural network changes between modules without functional alterations were identified in CIS patients, while more widespread and severe alterations in structural networks and disrupted inter-module efficiency in functional networks were observed in MS patients. The structural network changes were associated with cognitive impairment and physical disability.
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CIS

:   clinically isolated syndrome

DTI

:   diffusion tensor imaging

EDSS

:   Expanded Disability Status Scale

MMSE

:   Mini-Mental State Examination

MRI

:   magnetic resonance imaging

MS

:   multiple sclerosis

PASAT

:   Paced Auditory Serial Addition Test

rs-fMRI

:   resting-state functional MRI
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